NANO – MANDATORY NOTIFICATION OF TRADE

Fri, Jun 19, 2015 16:12 CET

Oslo, Norway 19 June 2015: Ludvik Sandnes, chairman of the Board of Directors of Nordic Nanovector ASA, has today purchased 2,626 shares in Nordic Nanovector ASA at an average share price of NOK 30,00 per share, through his 100% owned company Ekornhuset AS.

Following the transaction, Ludvik Sandnes directly and indirectly will own 125,000 shares in Nordic Nanovector ASA.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Tags:

Cancer Therapy non-hodgkins lymphoma Betalutin Nordic Nanovector Radioimmunotherapy Roy Hartvig Larsen anticancer therapeutics

NANO – MANDATORY NOTIFICATION OF TRADE

Subscribe